Mycoplasma pneumoniae IgG Control Serum BC127G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Mycoplasma pneumoniae IgG Control Serum
Applications: ELISA
IgG control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC127G Categories: control serum, Virion/Serion kits Tags: ELISA control serum, IgG, Mycoplasma pneumoniae

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Mycoplasma pneumoniae reactive IgG
species reactivity	Mycoplasma pneumoniae
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Mycoplasma pneumoniae IgG Control Serum BC127G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Mycoplasma pneumoniae Antigen (BA127VS) Mycoplasma pneumoniae P1 Antigen (BA127VSP1) Mycoplasma pneumoniae IgA Control Serum (BC127A) Mycoplasma pneumoniae IgG Control Serum (BC127G) Mycoplasma pneumoniae IgM Control Serum (BC127M) Mycoplasma pneumoniae IgA ELISA Kit (ESR127A) Mycoplasma pneumoniae IgG ELISA Kit (ESR127G) Mycoplasma pneumoniae IgM ELISA Kit (ESR127M)

target relevance

human antibody anti-Mycoplasma pneumoniae

Mycoplasma pneumoniae

Description
Bacterium that causes atypical pneumonia and respiratory tract infections

Structure
Mycoplasma pneumoniae is a small, self-replicating bacterium belonging to the family Mycoplasmataceae. Unlike most bacteria, M. pneumoniae lacks a cell wall and is instead surrounded by a sterol-containing cell membrane, making it naturally resistant to beta-lactam antibiotics such as penicillins and cephalosporins. The organism is highly specialized for colonization of the human respiratory tract, where it attaches to ciliated epithelial cells using a specialized attachment organelle. Mycoplasma pneumoniae is one of the smallest free-living organisms capable of independent replication and possesses a highly reduced genome reflecting its dependence on host-derived nutrients. The bacterium is transmitted through respiratory droplets and is a common cause of community-acquired respiratory infections worldwide, particularly among school-aged children, adolescents, and young adults.

Diagnosis
The diagnosis of Mycoplasma pneumoniae infection is performed through molecular, serological, and microbiological methods. Polymerase chain reaction (PCR) assays are considered the most sensitive and specific diagnostic tools and allow rapid detection of M. pneumoniae DNA from respiratory specimens. Serological assays, including ELISA-based tests, are commonly used to detect Mycoplasma-specific IgM and IgG antibodies and may assist in the diagnosis of acute or recent infection. Culture of M. pneumoniae is possible using specialized media but is rarely performed in routine clinical practice due to slow growth and technical complexity. Chest radiography may reveal diffuse or patchy infiltrates that are often disproportionate to the severity of clinical symptoms. Laboratory confirmation is particularly useful because clinical findings frequently overlap with those of viral respiratory infections.

Symptoms
Mycoplasma pneumoniae infection typically develops following an incubation period of approximately one to four weeks. Common symptoms include persistent dry cough, sore throat, fever, headache, fatigue, and malaise. Respiratory illness often begins gradually and may progress from upper respiratory tract infection to atypical pneumonia characterized by prolonged cough and diffuse pulmonary involvement. Many patients remain ambulatory despite radiographic evidence of pneumonia, leading to the term 'walking pneumonia.' Extrapulmonary manifestations may occur and can include skin rashes, hemolytic anemia, myocarditis, pericarditis, hepatitis, arthritis, and neurological complications such as encephalitis or Guillain-Barré syndrome. Although most infections are self-limiting, severe disease may occur in immunocompromised individuals and patients with underlying respiratory conditions.

Data

FAQ & Publications

Frequently Asked Questions

What is the intended application of the Mycoplasma pneumoniae IgG Control Serum BC127G?

The Mycoplasma pneumoniae IgG Control Serum BC127G is designed for use as a control serum in ELISA assays, specifically for indirect and quantitative detection of IgG antibodies against Mycoplasma pneumoniae.

Is the Mycoplasma pneumoniae IgG Control Serum BC127G ready to use or does it require dilution?

This control serum is provided ready-to-use and pre-diluted for compatibility with SERION ELISA classic and SERION ELISA antigen assays.

At what temperature should the Mycoplasma pneumoniae IgG Control Serum BC127G be stored?

The control serum should be stored refrigerated at 2-8°C to maintain stability and functionality.

Does the Mycoplasma pneumoniae IgG Control Serum BC127G react with species other than Mycoplasma pneumoniae?

The serum specifically contains IgG reactive to Mycoplasma pneumoniae and is intended for detection of antibodies against this species.

What is the volume of the Mycoplasma pneumoniae IgG Control Serum BC127G supplied?

The product is supplied in a 3 mL volume.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC127G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Mycoplasma pneumoniae IgG Control Serum BC127G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Cytomegalovirus IgG Control Serum BC109G

Brucella IgG Control Serum BC116G

Enterovirus IgG Control Serum BC133G

Borrelia burgdorferi IgG Control Serum BC121G

Echovirus IgG Control Serum BC135G

Bordetella pertussis IgG Control Serum BC120G

Echinococcus IgG Control Serum BC107G

Aspergillus fumigatus IgG Control Serum BC132G

Diphtheria IgG Control Serum BC130G

Adenovirus IgG Control Serum BC128G

Coxsackie IgG Virus Control Serum BC134G

Chlamydia trachomatis IgG Control Serum BC1372G

Chlamydia pneumoniae IgG Control Serum BC1371G

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G